type I pneumocyte

**Structure & function** - Extremely thin (~0.1–0.2 µm) squamous epithelial cells covering ~95% of alveolar surface area (but only ~40% of the alveolar epithelial cell count; type II cells are more numerous but cover only ~5% of the surface). - Main function: gas exchange (O2/CO2 diffusion by simple diffusion). Joined by tight junctions, which prevent fluid leak into the alveolar space. - Part of the blood-air barrier: surfactant layer → type I pneumocyte → fused basement membranes (type I pneumocyte + capillary endothelium) → capillary endothelial cell. Fused basal laminae minimize diffusion distance. - Express markers such as aquaporin-5, T1α (podoplanin), and RAGE (receptor for advanced glycation end-products). They also help with alveolar fluid clearance (ion/water transport).

**Type I vs type II pneumocytes (high-yield)** - Type I: squamous, thin, gas exchange, ~95% of surface area, terminally differentiated and susceptible to injury (cannot replicate). - Type II: cuboidal, secrete surfactant (DPPC/lecithin, dipalmitoylphosphatidylcholine), contain lamellar bodies, are the progenitor cells that proliferate and differentiate into type I cells after injury, and also secrete cytokines/other molecules and help with immune defense. - Alveolar macrophages (dust cells) are separate cells that phagocytose debris within alveoli.

**Clinical significance** - Diffuse alveolar damage (ARDS): injury to type I cells and capillary endothelium → increased permeability → protein-rich edema, hyaline membranes (necrotic cell debris + fibrin/protein), impaired gas exchange, and decreased compliance. Type II cell hyperplasia occurs during the reparative phase. - Because type I cells are lost, type II hyperplasia is a typical histologic repair response (e.g., ARDS, organizing phase, pneumonia recovery). - Infant respiratory distress syndrome: surfactant deficiency from immature type II cells (produce surfactant starting ~week 24–28; mature by ~35 weeks) → alveolar collapse and hyaline membrane formation. Type I cells are present but damaged secondarily. - Pulmonary edema, oxygen toxicity, and inhaled toxins (e.g., high FiO2, paraquat, smoke, chlorine) damage type I cells. - Diffusion-limited conditions (e.g., interstitial lung disease, pulmonary fibrosis) thicken the diffusion barrier → decreased DLCO.

**Embryology** - Type I and II cells develop during the saccular/alveolar stages (type II cells appear first, around week 24 of the canalicular-saccular transition; type II cells later differentiate into type I). Fetal lung development: embryonic → pseudoglandular → canalicular → saccular → alveolar.

**Pearls** - "Type 1 = Thin and for gas exchange; Type 2 = Secretes surfactant and Stem-like (repair)." - Fick's law: diffusion ∝ (area × ΔP × solubility) / thickness. Type I cells provide a large area and short diffusion distance.